- Market observers wait for Komipharm drug test approvals, hoping to invest in company shares
- Korea Exchange has warned against unchecked fluctuations in coronavirus-themed stocks
- The company experienced an upward streak in their stocks for five consecutive days
According to a report by The Korea Herald, Komipharm is confident about the upcoming develop....
Tags : KOMIPHARM, KOSDAQ, STOCK MARKET, STOCK PRICE RISE, DRUG APPROVAL, PANAPHIX,